Abatacept Rescue Therapy in Kidney Transplant Recipients: A Case Series of Five Patients
Sign Up to like & getrecommendations! Published in 2022 at "Transplant International"
DOI: 10.3389/ti.2022.10681
Abstract: Dear Editors, Abatacept, a cytotoxic T-lymphocyte-associated antigen 4 immunoglobulin (CTLA4-Ig), is a subcutaneously administered immunosuppressive drug that selectively inhibits T-cell activation by blocking the CD28-CD80/86 costimulatory pathway. Abatacept is widely used in rheumatology, especially in… read more here.
Keywords: five patients; abatacept rescue; therapy; rescue therapy ... See more keywords